nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—Loperamide—Tamoxifen—pancreatic cancer	0.246	0.593	CrCrCtD
Fexofenadine—Methadone—Tamoxifen—pancreatic cancer	0.169	0.407	CrCrCtD
Fexofenadine—SLCO2B1—Erlotinib—pancreatic cancer	0.149	0.303	CbGbCtD
Fexofenadine—SLCO1B3—Docetaxel—pancreatic cancer	0.0873	0.178	CbGbCtD
Fexofenadine—SLCO1B1—Irinotecan—pancreatic cancer	0.0694	0.141	CbGbCtD
Fexofenadine—ABCB1—Tamoxifen—pancreatic cancer	0.0259	0.0528	CbGbCtD
Fexofenadine—CYP2D6—Tamoxifen—pancreatic cancer	0.0244	0.0497	CbGbCtD
Fexofenadine—ABCB1—Gemcitabine—pancreatic cancer	0.0223	0.0455	CbGbCtD
Fexofenadine—ABCB1—Erlotinib—pancreatic cancer	0.022	0.0449	CbGbCtD
Fexofenadine—CYP2D6—Erlotinib—pancreatic cancer	0.0207	0.0423	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—pancreatic cancer	0.0199	0.0405	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—pancreatic cancer	0.0146	0.0297	CbGbCtD
Fexofenadine—ABCB1—Sunitinib—pancreatic cancer	0.0145	0.0296	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—pancreatic cancer	0.0109	0.0221	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—pancreatic cancer	0.0102	0.0209	CbGbCtD
Fexofenadine—Infection—Erlotinib—pancreatic cancer	0.000427	0.00475	CcSEcCtD
Fexofenadine—Angioedema—Sunitinib—pancreatic cancer	0.000417	0.00463	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—pancreatic cancer	0.00041	0.00456	CcSEcCtD
Fexofenadine—Flushing—Irinotecan—pancreatic cancer	0.0004	0.00445	CcSEcCtD
Fexofenadine—Cough—Sunitinib—pancreatic cancer	0.000398	0.00442	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000396	0.0044	CcSEcCtD
Fexofenadine—Insomnia—Tamoxifen—pancreatic cancer	0.000393	0.00437	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000392	0.00435	CcSEcCtD
Fexofenadine—Insomnia—Erlotinib—pancreatic cancer	0.000389	0.00432	CcSEcCtD
Fexofenadine—Myalgia—Sunitinib—pancreatic cancer	0.000388	0.00432	CcSEcCtD
Fexofenadine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000387	0.00431	CcSEcCtD
Fexofenadine—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000385	0.00429	CcSEcCtD
Fexofenadine—Dyspnoea—Erlotinib—pancreatic cancer	0.000383	0.00426	CcSEcCtD
Fexofenadine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000382	0.00425	CcSEcCtD
Fexofenadine—Dry mouth—Sunitinib—pancreatic cancer	0.00038	0.00422	CcSEcCtD
Fexofenadine—Dyspepsia—Erlotinib—pancreatic cancer	0.000378	0.00421	CcSEcCtD
Fexofenadine—Fatigue—Tamoxifen—pancreatic cancer	0.000375	0.00417	CcSEcCtD
Fexofenadine—Pain—Tamoxifen—pancreatic cancer	0.000372	0.00413	CcSEcCtD
Fexofenadine—Fatigue—Erlotinib—pancreatic cancer	0.000371	0.00412	CcSEcCtD
Fexofenadine—Flatulence—Irinotecan—pancreatic cancer	0.00037	0.00412	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—pancreatic cancer	0.00037	0.00411	CcSEcCtD
Fexofenadine—Infection—Sunitinib—pancreatic cancer	0.00037	0.00411	CcSEcCtD
Fexofenadine—Pain—Erlotinib—pancreatic cancer	0.000368	0.00409	CcSEcCtD
Fexofenadine—Back pain—Irinotecan—pancreatic cancer	0.000363	0.00404	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000355	0.00395	CcSEcCtD
Fexofenadine—Back pain—Gemcitabine—pancreatic cancer	0.000354	0.00394	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000351	0.00391	CcSEcCtD
Fexofenadine—Urticaria—Tamoxifen—pancreatic cancer	0.000345	0.00384	CcSEcCtD
Fexofenadine—Abdominal pain—Tamoxifen—pancreatic cancer	0.000343	0.00382	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—pancreatic cancer	0.000342	0.00381	CcSEcCtD
Fexofenadine—Body temperature increased—Erlotinib—pancreatic cancer	0.00034	0.00378	CcSEcCtD
Fexofenadine—Abdominal pain—Erlotinib—pancreatic cancer	0.00034	0.00378	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000339	0.00377	CcSEcCtD
Fexofenadine—Vision blurred—Fluorouracil—pancreatic cancer	0.000339	0.00377	CcSEcCtD
Fexofenadine—Insomnia—Sunitinib—pancreatic cancer	0.000337	0.00374	CcSEcCtD
Fexofenadine—Dyspnoea—Sunitinib—pancreatic cancer	0.000332	0.00369	CcSEcCtD
Fexofenadine—Cough—Irinotecan—pancreatic cancer	0.000328	0.00364	CcSEcCtD
Fexofenadine—Dyspepsia—Sunitinib—pancreatic cancer	0.000328	0.00364	CcSEcCtD
Fexofenadine—Fatigue—Sunitinib—pancreatic cancer	0.000321	0.00357	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000321	0.00357	CcSEcCtD
Fexofenadine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00032	0.00356	CcSEcCtD
Fexofenadine—Cough—Gemcitabine—pancreatic cancer	0.000319	0.00355	CcSEcCtD
Fexofenadine—Pain—Sunitinib—pancreatic cancer	0.000318	0.00354	CcSEcCtD
Fexofenadine—Epistaxis—Docetaxel—pancreatic cancer	0.000313	0.00348	CcSEcCtD
Fexofenadine—Asthenia—Tamoxifen—pancreatic cancer	0.000312	0.00347	CcSEcCtD
Fexofenadine—Myalgia—Gemcitabine—pancreatic cancer	0.000311	0.00346	CcSEcCtD
Fexofenadine—Increased appetite—Epirubicin—pancreatic cancer	0.000309	0.00344	CcSEcCtD
Fexofenadine—Asthenia—Erlotinib—pancreatic cancer	0.000308	0.00343	CcSEcCtD
Fexofenadine—Pruritus—Tamoxifen—pancreatic cancer	0.000307	0.00342	CcSEcCtD
Fexofenadine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000306	0.00341	CcSEcCtD
Fexofenadine—Myalgia—Fluorouracil—pancreatic cancer	0.000306	0.00341	CcSEcCtD
Fexofenadine—Infection—Irinotecan—pancreatic cancer	0.000304	0.00339	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000304	0.00338	CcSEcCtD
Fexofenadine—Pruritus—Erlotinib—pancreatic cancer	0.000304	0.00338	CcSEcCtD
Fexofenadine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000299	0.00332	CcSEcCtD
Fexofenadine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000297	0.00331	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000297	0.0033	CcSEcCtD
Fexofenadine—Infection—Gemcitabine—pancreatic cancer	0.000297	0.0033	CcSEcCtD
Fexofenadine—Abdominal pain—Sunitinib—pancreatic cancer	0.000294	0.00327	CcSEcCtD
Fexofenadine—Body temperature increased—Sunitinib—pancreatic cancer	0.000294	0.00327	CcSEcCtD
Fexofenadine—Diarrhoea—Erlotinib—pancreatic cancer	0.000294	0.00327	CcSEcCtD
Fexofenadine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000294	0.00326	CcSEcCtD
Fexofenadine—Infection—Fluorouracil—pancreatic cancer	0.000292	0.00324	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—pancreatic cancer	0.000291	0.00323	CcSEcCtD
Fexofenadine—Dizziness—Tamoxifen—pancreatic cancer	0.000287	0.00319	CcSEcCtD
Fexofenadine—Tachycardia—Fluorouracil—pancreatic cancer	0.000286	0.00319	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—pancreatic cancer	0.000286	0.00318	CcSEcCtD
Fexofenadine—Dizziness—Erlotinib—pancreatic cancer	0.000284	0.00316	CcSEcCtD
Fexofenadine—Insomnia—Irinotecan—pancreatic cancer	0.000277	0.00308	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—pancreatic cancer	0.000277	0.00308	CcSEcCtD
Fexofenadine—Vomiting—Tamoxifen—pancreatic cancer	0.000276	0.00307	CcSEcCtD
Fexofenadine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000274	0.00305	CcSEcCtD
Fexofenadine—Rash—Tamoxifen—pancreatic cancer	0.000274	0.00305	CcSEcCtD
Fexofenadine—Dermatitis—Tamoxifen—pancreatic cancer	0.000274	0.00304	CcSEcCtD
Fexofenadine—Vomiting—Erlotinib—pancreatic cancer	0.000273	0.00304	CcSEcCtD
Fexofenadine—Dyspnoea—Irinotecan—pancreatic cancer	0.000273	0.00304	CcSEcCtD
Fexofenadine—Somnolence—Irinotecan—pancreatic cancer	0.000272	0.00303	CcSEcCtD
Fexofenadine—Headache—Tamoxifen—pancreatic cancer	0.000272	0.00303	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000272	0.00302	CcSEcCtD
Fexofenadine—Rash—Erlotinib—pancreatic cancer	0.000271	0.00301	CcSEcCtD
Fexofenadine—Dermatitis—Erlotinib—pancreatic cancer	0.000271	0.00301	CcSEcCtD
Fexofenadine—Insomnia—Gemcitabine—pancreatic cancer	0.00027	0.003	CcSEcCtD
Fexofenadine—Dyspepsia—Irinotecan—pancreatic cancer	0.00027	0.003	CcSEcCtD
Fexofenadine—Headache—Erlotinib—pancreatic cancer	0.000269	0.00299	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—pancreatic cancer	0.000269	0.00299	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000267	0.00297	CcSEcCtD
Fexofenadine—Asthenia—Sunitinib—pancreatic cancer	0.000267	0.00297	CcSEcCtD
Fexofenadine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000266	0.00296	CcSEcCtD
Fexofenadine—Insomnia—Fluorouracil—pancreatic cancer	0.000266	0.00295	CcSEcCtD
Fexofenadine—Somnolence—Gemcitabine—pancreatic cancer	0.000265	0.00295	CcSEcCtD
Fexofenadine—Fatigue—Irinotecan—pancreatic cancer	0.000264	0.00294	CcSEcCtD
Fexofenadine—Pruritus—Sunitinib—pancreatic cancer	0.000263	0.00293	CcSEcCtD
Fexofenadine—Pain—Irinotecan—pancreatic cancer	0.000262	0.00291	CcSEcCtD
Fexofenadine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000262	0.00291	CcSEcCtD
Fexofenadine—Somnolence—Fluorouracil—pancreatic cancer	0.000261	0.0029	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00026	0.00289	CcSEcCtD
Fexofenadine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000258	0.00287	CcSEcCtD
Fexofenadine—Nausea—Tamoxifen—pancreatic cancer	0.000258	0.00287	CcSEcCtD
Fexofenadine—Fatigue—Gemcitabine—pancreatic cancer	0.000257	0.00286	CcSEcCtD
Fexofenadine—Pain—Gemcitabine—pancreatic cancer	0.000255	0.00284	CcSEcCtD
Fexofenadine—Nausea—Erlotinib—pancreatic cancer	0.000255	0.00284	CcSEcCtD
Fexofenadine—Diarrhoea—Sunitinib—pancreatic cancer	0.000255	0.00283	CcSEcCtD
Fexofenadine—Back pain—Docetaxel—pancreatic cancer	0.000251	0.00279	CcSEcCtD
Fexofenadine—Pain—Fluorouracil—pancreatic cancer	0.000251	0.00279	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000251	0.00279	CcSEcCtD
Fexofenadine—Dizziness—Sunitinib—pancreatic cancer	0.000246	0.00274	CcSEcCtD
Fexofenadine—Abdominal pain—Irinotecan—pancreatic cancer	0.000242	0.00269	CcSEcCtD
Fexofenadine—Body temperature increased—Irinotecan—pancreatic cancer	0.000242	0.00269	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000241	0.00268	CcSEcCtD
Fexofenadine—Vomiting—Sunitinib—pancreatic cancer	0.000237	0.00263	CcSEcCtD
Fexofenadine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000236	0.00262	CcSEcCtD
Fexofenadine—Rash—Sunitinib—pancreatic cancer	0.000235	0.00261	CcSEcCtD
Fexofenadine—Dermatitis—Sunitinib—pancreatic cancer	0.000234	0.00261	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000234	0.0026	CcSEcCtD
Fexofenadine—Urticaria—Fluorouracil—pancreatic cancer	0.000233	0.00259	CcSEcCtD
Fexofenadine—Headache—Sunitinib—pancreatic cancer	0.000233	0.00259	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—pancreatic cancer	0.000232	0.00258	CcSEcCtD
Fexofenadine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000232	0.00258	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—pancreatic cancer	0.000229	0.00255	CcSEcCtD
Fexofenadine—Cough—Docetaxel—pancreatic cancer	0.000227	0.00252	CcSEcCtD
Fexofenadine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000226	0.00251	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—pancreatic cancer	0.000224	0.00249	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—pancreatic cancer	0.000221	0.00246	CcSEcCtD
Fexofenadine—Nausea—Sunitinib—pancreatic cancer	0.000221	0.00246	CcSEcCtD
Fexofenadine—Asthenia—Irinotecan—pancreatic cancer	0.00022	0.00245	CcSEcCtD
Fexofenadine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000216	0.00241	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—pancreatic cancer	0.000216	0.0024	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000216	0.0024	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000215	0.00239	CcSEcCtD
Fexofenadine—Asthenia—Gemcitabine—pancreatic cancer	0.000214	0.00238	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000212	0.00236	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—pancreatic cancer	0.000211	0.00235	CcSEcCtD
Fexofenadine—Pruritus—Gemcitabine—pancreatic cancer	0.000211	0.00235	CcSEcCtD
Fexofenadine—Infection—Docetaxel—pancreatic cancer	0.00021	0.00234	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—pancreatic cancer	0.00021	0.00234	CcSEcCtD
Fexofenadine—Diarrhoea—Irinotecan—pancreatic cancer	0.00021	0.00233	CcSEcCtD
Fexofenadine—Pruritus—Fluorouracil—pancreatic cancer	0.000208	0.00231	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—pancreatic cancer	0.000207	0.00231	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—pancreatic cancer	0.000207	0.0023	CcSEcCtD
Fexofenadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000204	0.00227	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—pancreatic cancer	0.000203	0.00225	CcSEcCtD
Fexofenadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000201	0.00223	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—pancreatic cancer	0.000196	0.00217	CcSEcCtD
Fexofenadine—Vomiting—Irinotecan—pancreatic cancer	0.000195	0.00217	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—pancreatic cancer	0.000195	0.00216	CcSEcCtD
Fexofenadine—Dizziness—Fluorouracil—pancreatic cancer	0.000194	0.00216	CcSEcCtD
Fexofenadine—Rash—Irinotecan—pancreatic cancer	0.000193	0.00215	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—pancreatic cancer	0.000193	0.00215	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000193	0.00215	CcSEcCtD
Fexofenadine—Headache—Irinotecan—pancreatic cancer	0.000192	0.00214	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—pancreatic cancer	0.000192	0.00213	CcSEcCtD
Fexofenadine—Vomiting—Gemcitabine—pancreatic cancer	0.00019	0.00211	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—pancreatic cancer	0.000189	0.0021	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—pancreatic cancer	0.000188	0.00209	CcSEcCtD
Fexofenadine—Rash—Gemcitabine—pancreatic cancer	0.000188	0.00209	CcSEcCtD
Fexofenadine—Dermatitis—Gemcitabine—pancreatic cancer	0.000188	0.00209	CcSEcCtD
Fexofenadine—Headache—Gemcitabine—pancreatic cancer	0.000187	0.00208	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—pancreatic cancer	0.000187	0.00208	CcSEcCtD
Fexofenadine—Vomiting—Fluorouracil—pancreatic cancer	0.000187	0.00208	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—pancreatic cancer	0.000187	0.00207	CcSEcCtD
Fexofenadine—Rash—Fluorouracil—pancreatic cancer	0.000185	0.00206	CcSEcCtD
Fexofenadine—Dermatitis—Fluorouracil—pancreatic cancer	0.000185	0.00206	CcSEcCtD
Fexofenadine—Headache—Fluorouracil—pancreatic cancer	0.000184	0.00205	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—pancreatic cancer	0.000183	0.00203	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—pancreatic cancer	0.000182	0.00202	CcSEcCtD
Fexofenadine—Pain—Docetaxel—pancreatic cancer	0.000181	0.00201	CcSEcCtD
Fexofenadine—Nausea—Gemcitabine—pancreatic cancer	0.000177	0.00197	CcSEcCtD
Fexofenadine—Nausea—Fluorouracil—pancreatic cancer	0.000174	0.00194	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000173	0.00193	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—pancreatic cancer	0.000173	0.00192	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—pancreatic cancer	0.000173	0.00192	CcSEcCtD
Fexofenadine—Tension—Epirubicin—pancreatic cancer	0.000172	0.00191	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—pancreatic cancer	0.00017	0.00189	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—pancreatic cancer	0.000169	0.00188	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—pancreatic cancer	0.000167	0.00186	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—pancreatic cancer	0.000167	0.00186	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—pancreatic cancer	0.000165	0.00184	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—pancreatic cancer	0.000161	0.00179	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—pancreatic cancer	0.00016	0.00178	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—pancreatic cancer	0.000159	0.00177	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—pancreatic cancer	0.000157	0.00175	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—pancreatic cancer	0.000157	0.00174	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000156	0.00174	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—pancreatic cancer	0.000155	0.00172	CcSEcCtD
Fexofenadine—Cough—Epirubicin—pancreatic cancer	0.000153	0.0017	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—pancreatic cancer	0.000153	0.0017	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—pancreatic cancer	0.000152	0.00169	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—pancreatic cancer	0.00015	0.00167	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—pancreatic cancer	0.000149	0.00166	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—pancreatic cancer	0.000149	0.00166	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—pancreatic cancer	0.000146	0.00162	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—pancreatic cancer	0.000145	0.00161	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—pancreatic cancer	0.000143	0.00159	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000143	0.00159	CcSEcCtD
Fexofenadine—Infection—Epirubicin—pancreatic cancer	0.000142	0.00158	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—pancreatic cancer	0.000141	0.00157	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—pancreatic cancer	0.00014	0.00156	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—pancreatic cancer	0.000139	0.00155	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—pancreatic cancer	0.000138	0.00153	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—pancreatic cancer	0.000135	0.0015	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—pancreatic cancer	0.000135	0.0015	CcSEcCtD
Fexofenadine—Rash—Docetaxel—pancreatic cancer	0.000134	0.00149	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—pancreatic cancer	0.000133	0.00148	CcSEcCtD
Fexofenadine—Headache—Docetaxel—pancreatic cancer	0.000133	0.00148	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000132	0.00147	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—pancreatic cancer	0.000131	0.00146	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00013	0.00145	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—pancreatic cancer	0.000129	0.00144	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—pancreatic cancer	0.000129	0.00144	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—pancreatic cancer	0.000127	0.00142	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—pancreatic cancer	0.000127	0.00141	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—pancreatic cancer	0.000126	0.0014	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—pancreatic cancer	0.000126	0.0014	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—pancreatic cancer	0.000123	0.00137	CcSEcCtD
Fexofenadine—Pain—Epirubicin—pancreatic cancer	0.000122	0.00136	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00012	0.00134	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—pancreatic cancer	0.00012	0.00133	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000118	0.00131	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—pancreatic cancer	0.000118	0.00131	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000117	0.0013	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000116	0.00129	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—pancreatic cancer	0.000114	0.00127	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—pancreatic cancer	0.000114	0.00126	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—pancreatic cancer	0.000113	0.00126	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—pancreatic cancer	0.000113	0.00126	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—pancreatic cancer	0.000113	0.00126	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000108	0.0012	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000105	0.00117	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—pancreatic cancer	0.000105	0.00117	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000105	0.00116	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000105	0.00116	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—pancreatic cancer	0.000103	0.00114	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—pancreatic cancer	0.000101	0.00112	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—pancreatic cancer	9.78e-05	0.00109	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—pancreatic cancer	9.74e-05	0.00108	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—pancreatic cancer	9.49e-05	0.00106	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—pancreatic cancer	9.45e-05	0.00105	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—pancreatic cancer	9.36e-05	0.00104	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—pancreatic cancer	9.09e-05	0.00101	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—pancreatic cancer	9.05e-05	0.00101	CcSEcCtD
Fexofenadine—Rash—Epirubicin—pancreatic cancer	9.01e-05	0.001	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—pancreatic cancer	9e-05	0.001	CcSEcCtD
Fexofenadine—Headache—Epirubicin—pancreatic cancer	8.95e-05	0.000996	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—pancreatic cancer	8.74e-05	0.000972	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—pancreatic cancer	8.49e-05	0.000944	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—pancreatic cancer	8.41e-05	0.000935	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—pancreatic cancer	8.34e-05	0.000927	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—pancreatic cancer	8.33e-05	0.000926	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—pancreatic cancer	8.28e-05	0.000921	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—pancreatic cancer	7.85e-05	0.000873	CcSEcCtD
Fexofenadine—SLCO1B3—Metabolism—DPYD—pancreatic cancer	8.1e-06	0.00167	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TYMP—pancreatic cancer	8.03e-06	0.00165	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	8.01e-06	0.00165	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ARG2—pancreatic cancer	7.85e-06	0.00162	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	7.77e-06	0.0016	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—SLC2A2—pancreatic cancer	7.69e-06	0.00158	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.61e-06	0.00157	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	7.43e-06	0.00153	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	7.37e-06	0.00152	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.34e-06	0.00151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GAST—pancreatic cancer	7.06e-06	0.00145	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	7.03e-06	0.00145	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TYMP—pancreatic cancer	6.86e-06	0.00141	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	6.85e-06	0.00141	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	6.85e-06	0.00141	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	6.82e-06	0.0014	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	6.74e-06	0.00139	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—SCT—pancreatic cancer	6.69e-06	0.00138	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.69e-06	0.00138	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.62e-06	0.00136	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	6.47e-06	0.00133	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	6.4e-06	0.00132	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCK—pancreatic cancer	6.38e-06	0.00131	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—DPYD—pancreatic cancer	6.37e-06	0.00131	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	6.37e-06	0.00131	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	6.33e-06	0.0013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	6.22e-06	0.00128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	6.22e-06	0.00128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	6.12e-06	0.00126	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	6.07e-06	0.00125	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	6.06e-06	0.00125	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	6.04e-06	0.00124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	6.01e-06	0.00124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	6.01e-06	0.00124	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.98e-06	0.00123	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CD44—pancreatic cancer	5.95e-06	0.00123	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.83e-06	0.0012	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	5.82e-06	0.0012	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.78e-06	0.00119	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.77e-06	0.00119	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GCG—pancreatic cancer	5.71e-06	0.00118	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.66e-06	0.00117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—SHH—pancreatic cancer	5.58e-06	0.00115	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	5.53e-06	0.00114	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.52e-06	0.00114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	5.51e-06	0.00113	CbGpPWpGaD
Fexofenadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.47e-06	0.00113	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—DPYD—pancreatic cancer	5.44e-06	0.00112	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	5.44e-06	0.00112	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DTX1—pancreatic cancer	5.44e-06	0.00112	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—STK11—pancreatic cancer	5.37e-06	0.00111	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—SST—pancreatic cancer	5.33e-06	0.0011	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	5.29e-06	0.00109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	5.29e-06	0.00109	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.26e-06	0.00108	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	5.22e-06	0.00108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	5.21e-06	0.00107	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	5.17e-06	0.00106	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPY—pancreatic cancer	5.11e-06	0.00105	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.11e-06	0.00105	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.04e-06	0.00104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	5.02e-06	0.00103	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.93e-06	0.00102	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	4.91e-06	0.00101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	4.85e-06	0.000999	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—SST—pancreatic cancer	4.84e-06	0.000996	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	4.82e-06	0.000993	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	4.76e-06	0.00098	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	4.75e-06	0.000978	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CD44—pancreatic cancer	4.68e-06	0.000964	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	4.65e-06	0.000959	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	4.62e-06	0.000951	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TYMS—pancreatic cancer	4.62e-06	0.000951	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.58e-06	0.000944	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DTX4—pancreatic cancer	4.56e-06	0.000939	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GLI1—pancreatic cancer	4.56e-06	0.000939	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.54e-06	0.000935	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PRSS1—pancreatic cancer	4.53e-06	0.000934	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	4.53e-06	0.000933	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.5e-06	0.000926	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.49e-06	0.000926	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GCG—pancreatic cancer	4.48e-06	0.000924	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	4.46e-06	0.000919	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	4.43e-06	0.000913	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRP1—pancreatic cancer	4.43e-06	0.000913	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.32e-06	0.00089	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GCG—pancreatic cancer	4.31e-06	0.000888	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	4.27e-06	0.00088	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HEY2—pancreatic cancer	4.27e-06	0.000879	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—STK11—pancreatic cancer	4.22e-06	0.000869	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.2e-06	0.000866	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GAST—pancreatic cancer	4.17e-06	0.000859	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.16e-06	0.000858	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.13e-06	0.000851	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	4.11e-06	0.000847	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.06e-06	0.000836	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD44—pancreatic cancer	4e-06	0.000824	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.96e-06	0.000815	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SCT—pancreatic cancer	3.95e-06	0.000814	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HEY1—pancreatic cancer	3.95e-06	0.000814	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ARG2—pancreatic cancer	3.93e-06	0.00081	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.92e-06	0.000807	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.88e-06	0.0008	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GCG—pancreatic cancer	3.84e-06	0.00079	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.82e-06	0.000787	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCK—pancreatic cancer	3.77e-06	0.000777	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.76e-06	0.000775	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOE—pancreatic cancer	3.75e-06	0.000773	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.7e-06	0.000763	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CNR2—pancreatic cancer	3.67e-06	0.000757	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	3.67e-06	0.000757	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	3.67e-06	0.000756	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.67e-06	0.000755	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TYMS—pancreatic cancer	3.63e-06	0.000747	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	3.61e-06	0.000745	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—STK11—pancreatic cancer	3.61e-06	0.000743	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.55e-06	0.000732	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAG2—pancreatic cancer	3.5e-06	0.000722	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MEN1—pancreatic cancer	3.45e-06	0.000712	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMP—pancreatic cancer	3.44e-06	0.000708	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	3.39e-06	0.000698	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.38e-06	0.000697	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.37e-06	0.000695	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.36e-06	0.000693	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.3e-06	0.000679	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SHH—pancreatic cancer	3.3e-06	0.000679	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	3.27e-06	0.000675	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—pancreatic cancer	3.27e-06	0.000674	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IAPP—pancreatic cancer	3.25e-06	0.00067	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMP—pancreatic cancer	3.24e-06	0.000667	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.14e-06	0.000647	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	3.12e-06	0.000643	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	3.12e-06	0.000643	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.12e-06	0.000642	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	3.1e-06	0.000639	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	2.98e-06	0.000614	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOE—pancreatic cancer	2.95e-06	0.000608	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.86e-06	0.00059	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SST—pancreatic cancer	2.86e-06	0.000589	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.82e-06	0.00058	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAG1—pancreatic cancer	2.8e-06	0.000576	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.79e-06	0.000575	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	2.78e-06	0.000574	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.77e-06	0.000571	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.77e-06	0.00057	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.73e-06	0.000561	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	2.66e-06	0.000548	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CNR1—pancreatic cancer	2.64e-06	0.000543	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.61e-06	0.000538	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	2.6e-06	0.000535	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.59e-06	0.000533	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	2.57e-06	0.00053	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—pancreatic cancer	2.57e-06	0.000529	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.57e-06	0.000529	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.56e-06	0.000527	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GCG—pancreatic cancer	2.55e-06	0.000525	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOE—pancreatic cancer	2.52e-06	0.00052	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.48e-06	0.00051	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.44e-06	0.000502	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	2.43e-06	0.0005	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STK11—pancreatic cancer	2.39e-06	0.000493	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.39e-06	0.000492	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	2.34e-06	0.000482	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.34e-06	0.000482	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	2.28e-06	0.000469	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.25e-06	0.000463	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—pancreatic cancer	2.24e-06	0.000462	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	2.2e-06	0.000453	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.16e-06	0.000445	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	2.1e-06	0.000432	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.07e-06	0.000427	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HES1—pancreatic cancer	2.05e-06	0.000422	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	2.04e-06	0.00042	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	2.02e-06	0.000416	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD44—pancreatic cancer	2e-06	0.000413	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	2e-06	0.000412	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.96e-06	0.000404	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCG—pancreatic cancer	1.92e-06	0.000396	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.89e-06	0.000389	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	1.88e-06	0.000388	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.81e-06	0.000373	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—STK11—pancreatic cancer	1.81e-06	0.000372	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—pancreatic cancer	1.79e-06	0.00037	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.76e-06	0.000363	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	1.74e-06	0.000359	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	1.73e-06	0.000356	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.72e-06	0.000353	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.71e-06	0.000353	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.7e-06	0.00035	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.67e-06	0.000345	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.64e-06	0.000338	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	1.58e-06	0.000326	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	1.56e-06	0.000322	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.55e-06	0.00032	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	1.55e-06	0.000318	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	1.51e-06	0.000311	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	1.51e-06	0.000311	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	1.51e-06	0.000311	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.49e-06	0.000308	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.46e-06	0.000301	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	1.38e-06	0.000284	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	1.33e-06	0.000274	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.32e-06	0.000271	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	1.3e-06	0.000268	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—pancreatic cancer	1.29e-06	0.000266	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOE—pancreatic cancer	1.26e-06	0.00026	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	1.24e-06	0.000256	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.2e-06	0.000246	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.19e-06	0.000245	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.16e-06	0.000239	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.14e-06	0.000235	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.11e-06	0.000229	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.11e-06	0.000228	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.1e-06	0.000227	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.08e-06	0.000221	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.07e-06	0.000221	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.07e-06	0.000219	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	1.06e-06	0.000219	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.04e-06	0.000214	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.04e-06	0.000214	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.03e-06	0.000212	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—pancreatic cancer	1.02e-06	0.000209	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.01e-06	0.000207	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1e-06	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1e-06	0.000206	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	9.76e-07	0.000201	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	9.44e-07	0.000194	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—pancreatic cancer	9.28e-07	0.000191	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	9.04e-07	0.000186	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	8.95e-07	0.000184	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	8.93e-07	0.000184	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	8.73e-07	0.00018	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	8.69e-07	0.000179	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—pancreatic cancer	8.65e-07	0.000178	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—pancreatic cancer	8.32e-07	0.000171	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	8.3e-07	0.000171	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.23e-07	0.00017	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.15e-07	0.000168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	8.14e-07	0.000168	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	7.69e-07	0.000158	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—pancreatic cancer	7.55e-07	0.000155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.11e-07	0.000146	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	7.06e-07	0.000145	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—pancreatic cancer	6.83e-07	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	6.53e-07	0.000135	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	5.77e-07	0.000119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	5.32e-07	0.00011	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	5.02e-07	0.000103	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—pancreatic cancer	4.35e-07	8.96e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.1e-07	8.44e-05	CbGpPWpGaD
